Medicare Advantage Plans – A Quiet Victory

 

Medicare Advantage plans are gaining in popularity. At least one-third of all Medicare patients have these plans and the numbers are growing.

What is a Medicare Advantage plan?

The Balanced Budget Act of 1997 introduced Medicare Part C and the term “Medicare + Choice” and the Medicare Prescription Drug, Improvement and Modernization Act of 2003 renamed “+ Choice” to Medicare Advantage. Both bills were passed by a Republican-controlled Congress.

Medicare Advantage plans pay for managed health care based on a monthly fee per enrollee (capitation), rather than on the basis of billing for each medical service provided (fee-for-service). Most such plans are health maintenance organizations (HMOs) or preferred provider organizations (PPOs). Medicare Advantage plans provide beneficiaries the same medical services via capitated-fee as “Original Medicare” Parts A and B Medicare provides via fee-for-service.

A Medicare Advantage beneficiary must first sign up for both Part A and Part B of Medicare but all three of these Parts, A, B and C, are administered by private insurance companies (usually the same insurance company). Part C health plans, including Medicare Advantage plans, not only cover the same medical services as Parts A and B but also typically include an annual physical exam and vision and/or dental coverage of some sort not covered under Original Medicare.

Less often, hearing and wellness benefits not found in Original Medicare are included in a Medicare Advantage plan. The most important difference between a Part C health plan and FFS Original Medicare is that all Part C plans, including capitated-fee Medicare Advantage plans, include a limit on how much a beneficiary will have to spend annually out of pocket; that amount is unlimited in Original Medicare.

Most but not all Medicare Advantage plans (and many of the other public managed-care health plans within Medicare Part C) include integrated self-administered drug coverage similar to the stand-alone Part D prescription drug benefit plan. The federal government makes separate capitated-fee payments to Medicare Advantage plans for providing these Part-D-like benefits if applicable just as it does for anyone on Original Medicare using Part D.

There are drawbacks to Medicare Advantage. Like all HMOs, you must pick your primary care provider from an approved list and must have a referral to see a specialist.The providers on the approved list have accepted lower reimbursement rates than original Medicare, and therefore may be in less demand than other physicians.

Growing Popularity

With the cost of healthcare rising rapidly, these plans are growing in popularity. Enrollment in Medicare Advantage plans has risen steadily, now exceeding 20 million or one-third of the Medicare market. They are projected to reach 40% of the market by 2024. If limiting healthcare expenses is your goal, this is your answer. If you prefer freedom of choice (and don’t mind the higher costs), stick with original Medicare.

Former Louisiana Governor Bobby Jindal, writing in The Wall Street Journal, warns Republicans to encourage these popular and successful plans by maintaining adequate funding. He says these privately-managed government-funded plans are doing a good job of keeping costs down by competing for patients. He says, “Specialized companies have sprung up to help avoid medication conflicts, manage specialty care, or prevent complications. Medical providers are taking risk and measuring patient outcomes, not just services performed.”

He suggests encouraging these plans by making them the default enrollment of new seniors while still allowing them to opt-out if they want original Medicare. He also suggests pursuing a similar program for seniors also enrolled in Medicaid.

The real “advantage” of these plans is lower costs and they are privately-managed. The less we allow the government to meddle in our healthcare, the better.

 

PRP and Stem Cells – Miracle Cure or Snake Oil?

 

Since the frontier days that established this great country, people have been selling snake oil to cure whatever ails you. Have things changed or is this déjà vu all over again?

If you’re not aware of the controversy I’m referring to, it’s the sudden surge of stem cell and plasma rich protein (PRP) treatments to treat sports injuries and other ailments of the body. Clinics are popping up all over the country with claims to cure a myriad of ailments – and prices to match these claims.

I recently attended the Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) in New Orleans, as I have done for the last 35 years, and this was definitely the hottest topic of the week. Many orthopedists, like myself, were eager to hear what the experts in the field had to say about this controversial topic.

The AAOS says there are over 570 clinics representing 351 businesses marketing “stem cell” treatments for orthopaedic problems. They say that most clinics use autologous “minimally manipulated” preparations that do not contain clinically significant numbers of stem cells. Widespread use of these cash-for-service, unproven, and poorly described treatments raises concerns for public health and safety.

Due to their concerns, the AAOS held a Symposium at Stanford University in February with the following objectives:

  1. Establish a clear, collective impact agenda for the clinical evaluation, use, and, optimization of biologics in orthopaedics
  2. Develop a guidance document on clinically meaningful endpoints and outcome metrics for the evaluation of biologics for common orthopaedic problems

 

Attendees at the Symposium agreed the following are needed:

  • Clear guidelines on the conduct and reporting requirements for clinical studies involving PRP
  • Disease-specific biologic targets and clinical outcomes
  • Clinical registries to examine outcomes

 

Areas of Treatment

Stem cell and PRP preparations are being used after rotator cuff and ACL surgery, for tendinopathy in multiple areas of the body, hamstring tears, osteoarthritis of the knee and meniscus injuries. While anecdotal evidence (case studies) suggests some usefulness, especially after rotator cuff repair, there are no double-blind clinical studies yet to document the effectiveness of these treatments.

Part of the problem is the lack of uniformity of stem cell and PRP preparations from one clinic to another. The result is widespread variations in the content of the preparations given. This means comparisons are difficult and conclusions meaningless.

Compounding the difficulty is the fact that these treatments are considered experimental and therefore not covered by health insurance. Clinicians have a wide variety of expertise from orthopaedic surgeons, to family practitioners, to pain management specialists, or anyone who calls themself a “sports medicine” doctor. Patients must be aware there is no national certification for these treatments.

There may be hope for the future in this area of “biologics” treatments but at present patients should have their eyes (and their wallets) open to the unproven success. Fortunately, there has been no clinical evidence yet that such treatments are harmful; just not necessarily helpful.

False Teachers Promote Single-Payer Healthcare

 

In this Easter season, it appears that Single-Payer healthcare is rising from the dead.

Sally Pipes, writing in Forbes, warns that false teachers are spreading the gospel of single-payer healthcare and the uninformed public is listening. Chief among these false teachers is single-payer evangelist and senator Bernie Sanders (D –VT). Though Sanders failed to win the Democratic nomination for president in 2016, he has apparently won over all the prominent Democratic candidates for the next election.

Congressional Democrats are getting on board, too. Sanders’ Medicare For All bill introduced in 2013 didn’t garner a single supporter. Today one in three Democrats in the Senate and sixty percent of House Democrats support a similar bill.

New research from the left-wing think tank Data For Progress claims a majority of voters in 42 states now favor single-payer. Even if this research is bias, it does reflect a disturbing trend. The same research from only last September showed fewer than half of Americans supported single-payer.

False teachers always makes false claims to convince others of the virtues of their ideas. Sanders and his minions are no different. They preach universal coverage and high-quality care – two things they can’t deliver. But it is an appealing claim for those on the outside looking in at our current healthcare system.

Alas, the public is ignorant, and that makes for fertile soil when trying to grow support for this healthcare change. But Americans need look no farther than their northern border, Canada, to see the problems of single-payer healthcare.

Pipes, a native of Canada, is very familiar with the evils of single-payer healthcare. Like all single-payer systems, Canada rations care to control costs. She says this rationing can occur in one of two ways:

  • Nationalizing hospitals and clinics
  • Low reimbursement rates for physicians and hospitals

 

Nationalizing Hospitals and Clinics

This is the system in Great Britain. The National Health Service (NHS) holds down costs by hiring a limited number of doctors and building relatively few hospitals. Shortages and delays are so bad in Great Britain that the British Red Cross last year warned the system was experiencing a “humanitarian crisis.”

Pipes says, “Amid chronic overcrowding during this winter’s flu season, NHS doctors were forced to treat over 100 patients a day in hospital hallways due to a lack of beds. Thousands of patients waited in ambulances for an hour or more before receiving care. Only one in three British patients is satisfied with the NHS, according to a recent poll.”

Low Reimbursement Rates

This is the system in Canada. The government sets such low reimbursements that the country suffers from a chronic, and worsening, shortage of doctors. Last year, the typical Canadian patient waited 21 weeks to receive treatment from a specialist after obtaining a referral from a general practitioner.

A recent study by the Commonwealth Fund found one in three Canadians 65 or older is dissatisfied with the quality of care. The study compared 11 developed countries and found that Canada ranks dead last on patient satisfaction scores. Wait lists are so long that many patients leave Canada to seek care abroad, even though they have to pay for treatments out of pocket. In 2017, an estimated 63,000 Canadians sought medical treatment in another country.

The facts on single-payer healthcare are well known to anyone who has studied the experiences of other countries such as Canada, Great Britain, or Sweden. The consistent and inevitable result will be the following:

  • Increased waiting times for diagnostic testing and treatment
  • Delayed or denied surgical procedures
  • Massive tax increases

 

Beware the false teachers who would try to convince you otherwise!

 

(For more on single-payer healthcare and socialized medicine, see the following posts: Single-Payer Advocates Distort the Truth, Single-Payer v. Market-Driven Healthcare, Single-Payer Wastes Money and Time (Parts I-V), or read my book, The ObamaCare Reality.)